PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of PaxMedica Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PaxMedica Inc market cap is $1,100.00.
What is the 52-week high for PaxMedica Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PaxMedica Inc 52 week high is $0.16 as of October 14, 2025.
What is the 52-week low for PaxMedica Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PaxMedica Inc 52 week low is $0.00 as of October 14, 2025.
What is PaxMedica Inc stock price today?
PaxMedica Inc stock price today is $0.0001.
What was PaxMedica Inc stock price yesterday?
PaxMedica Inc stock price yesterday was $0.0001.
What is the 50-day moving average of PaxMedica Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PaxMedica Inc 50-day moving average is $0.0002.